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SURVIVAL in a hostile environment requires the ability to mount a protective immune re-
sponse while avoiding a reaction of the im-
mune system against the sel£ We propose that the 
migration and localization of antigen are the govern-
ing factors in immunologic responsiveness or unre-
sponsiveness against infections, tumors, and self and 
against xenografts and allografts. This conclusion is 
based largely on studies of experimental viral infec-
tionl3 and of the small numbers of donor leukocytes 
found in the blood and tissues of human and animal 
recipients of organ allografts (microchimerism).4-6 
Under both circumstances, an immune response can 
be construed as a balance bttween potentially reac-
tive lymphocytes and the composition, quantity, ki-
netics, and distribution of antigen (foreign or self) 
in the host. 
CHARACTERISTICS OF THE IMMUNE 
RESPONSE 
The immune system reacts similarly against lethal 
cytopathic microorganisms and less dangerous non-
cytopathic ones, but with different consequences.I ,2,7,8 
Immune Responses against Microorganisms 
Cytoptlthie MictoorgtIm.m. 
In order to prevent damage to host cells by cyto-
pathic microorganisms, the full resources, first of the 
nonspecific (innate) and then of the specific (adap-
tive) immune system, are mobilized to eliminate the 
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damaging microorganisms quickly and completely, 
without regard for immune-mediated destruction of 
host tissues.I-3 The first line of defense is dominated 
by interferons, macrophages, ylB T cells, and natural 
killer cells. In addition, infectious invaders with 
densely arranged and ordered repetitive epitopes, 
or those containing lipopolysaccharides, can induce 
B cells to respond and secrete antibodies without 
T-cell help. Nonspecific or less specific effector mech-
anisms, such as complement, interleukins, and phag-
ocytes, are also involved. The specific T- and B-cell 
immune responses then usually control cytopathic 
microorganisms definitively. 
Noncytopflthif; MiclVtNfIItm.m. 
In contrast to cytopathic microorganisms, less cy-
topathic or noncytopathic microorganisms can be 
accommodated in ways that allow the host and 
pathogen to coexist. Intracellular microorganisms 
are primarily controlled by interleukin-releasing or 
cytolytic T cells that recognize host cells displaying 
complexes composed of major-histocompatibility-
complex (MHC) molecules plus peptides derived 
from the infecting microorganism.9,IO Because the 
microorganisms may be noninjurious, the immune 
response to them should not be one that causes 
damage to either normal or infected tissue. Other-
wise, the immune responses to and destruction of 
widely disseminated microorganisms (e.g., hepatitis 
B or C virus) might disable or even kill the host. To 
prevent this, the immune response can be tempered 
or terminated by mechanisms that may lead to vari-
ous degrees of antigen-specific nonreactivity. 
Immune Reactions against Transplants 
XMrogrstb 
The mechanisms of predominantly innate immu-
nity, induding complement-dependent cell destruc-
tion and others based on cross-reactive natural anti-
bodies, are responsible for the hyperacute rejection 
of xenografts. The best-characterized target antigen 
on the cells of discordant xenografts is the surface 
carbohydrate epitope galactose a(1-3)galactose. Since 
a(I-3)galactose or similar substances are also found 
on numerous bacteria, protozoa, and viruses,ll they 
are likely to be responsible for the preexisting natu-
ral antibodies. 
A/IognIft. 
In a prophetic early review, Lawrencel2 compared 
the stepwise rejection of primary allografts to infec-
tions associated with delayed hypersensitivity (e.g., 
tuberculosis). The MHC-restricted mechanisms of 
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Figure 1. Distribution of Donor Lsukocytes (Circles) Three Months after Kidney Transplantation. 
With the nearly complete disappearance from the allograft of donor leukocytes, the absence of which reduces the organ's Immu-
nogenlclty, the recipient's leukocytes replace them. The appearance of chimerism is visible In the nonlymphoid organs (skin, heart, 
and liver are shown), as is the communication between the nonlymphoid compartments and lymphoid compartments (spleen, 
thymus, lymph nodes, and bone marrow). 
the delayed hypersensitivity response were unknown 
at the time. Once they were recognized, it was ob-
vious that immune rejection of allografts was the 
physiologic equivalent of rejection of infected cells .1o 
MIGRATORY ROUTES OF ANTIGEN 
Because lymphoid organs are critical sites for in-
duction of the response against all antigens, the re-
sulting immune reactions can be correlated with 
both the routes of spread and the eventual localiza-
tion of antigen,l3 
Microorganisms 
The tissue tropism and pathogenicity of microor-
ganisms determine their migratory routes and desti-
nations. Many infectious microorganisms, particular-
ly of the cytopathic variety, or their component 
antigens, are transported within a few hours or days 
to the lymphoid organs, where a protective immune 
response is quickly induced. Others, especially those 
with few or no cytopathic qualities, may stay in im-
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munoprotected nonlymphoid locations; for exam-
ple, papillomaviruses may stay in keratinocytes or 
rabies virus in neurons. Some intracellular microor-
ganisms may take up residence in nonlymphoid sites 
after surviving for a short time in immune-compe-
tent lymphocytes (e.g., Epstein-Barr virus in B cells 
and human immunodeficiency virus [HIV] in CD4 
T cells) or after partially bypassing the lymphoid or-
gans during a generalized infection (e.g., the com-
mon hepatitis viruses) . This is often achieved by vi-
ruses in latent infections in which viral antigens are 
not expressed by the nonlymphoid cells or are not 
presented by the cells' MHC molecules (e.g., HIV 
in some lymphocytes). Alternatively, viral antigens 
may be expressed in cells that are difficult to reach 
by immune cells or antibodies (e.g., HIV in brain 
cells or cytomegalovirus in renal tubular cells). 
AIIog ... tu 
In the first few days after organ transplantation, 
multilineage, bone marrow-derived ("passenger") 
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leukocytes of donor origin constitute 1 to 20 per-
cent of the circulating mononuclear cells in the recip-
ient. The percentage depends on the organ that was 
transplanted; it is highest with liver and intestine and 
lowest with heart and kidney.s These leukocytes, 
which include pluripotent stem cells14,1S and dendritic 
cells,4-6,16-19 travel to the recipient's lymphoid or-
gansI6,17,20 and are largely replaced in the graft by sim-
ilar cells of the recipient.S,18,19,21 After about two weeks, 
increasing numbers of donor leukocytes can be de-
tected in other tissues,18,19,22 and by three months 
they are found mostly in nonlymphoid tissues (e.g., 
skin and heart).S,6,23 After two to four weeks, these 
leukocytes can be identified in blood or tissue sam-
ples only with sensitive immunocytochemical tech-
niques or with the polymerase chain reaction. The 
detection limit of these techniques is 1 donor cell per 
105 recipient cells.4-6,23 The kinetics and the eventual 
patchy distribution of the donor cells resemble those 
of spreading infections (Fig. 1).24 
MECHANISMS OF IMMUNOLOGIC 
NONREACTIVITY 
In the earliest studies of specific immunologic 
nonreactivity, lymphocytic choriomeningitis virus was 
found to persist after transplacental infection of the 
embryo from the mother or after injection of the 
virus into newborn mice, but it was eliminated im-
munologically in mice infected as adults.2s Immuno-
logic tolerance to allogeneic blood cells was first re-
ported in nonidentical twin calves with a common 
placental circulation that were mutually chimeric and 
therefore reciprocally tolerant.26 Subsequently, ex-
periments in which allogeneic donor splenocytes 
were infused into mice during fetal or early neonatal 
life found a strong correlation between engraftment 
of the donor leukocytes (chimerism) and subsequent 
acceptance of skin grafts from the donor strain (ac-
quired tolerance). 27 
In rabbits given bovine serum albumin while also 
being given mercaptopurine, the cytotoxic drug ren-
dered the animals tolerant of the foreign protein.28 
Similarly, manipulation of the immune response with 
mixtures of nonspecific immunosuppressive drugs 
administered at the time of organ allotransplantation 
reliably induced incomplete donor-specific tolerance,29 
providing a practical basis for clinical organ trans-
plantation. The mechanisms by which these various 
nonreactive states evolve have been controversial. 
Tolerance Induced by Clonal Deletion 
When relatively small numbers ofT cells are con-
fronted with an excess of antigen, they disappear 
(deletion). This phenomenon was long suspected to 
result from over stimulation of a subgroup of im-
mune cells by a variety of antigens,28,30,31 including 
allogeneic cells.32 Since 1990, the process, called 
clonal exhaustion or exhaustion-deletion, has been 
induced by infection with noncytopathic viruses, by 
retroviral superantigens, and by the injection of pep-
tides in varying doses without or with adjuvant or of 
cells expressing a defined foreign antigen (e.g., male 
H - Y antigen or bacterial superantigen). 8,33-36 The 
T cells that react against the specific antigen are ac-
tivated within a few days, end-differentiate to effec-
tor cells, and are deleted,l.37,38 The details are poorly 
understood, but cell death by interleukin depriva-
tion and other mechanisms associated with apopto-
sis seems to be involved.39,40 
Although thymic (central) deletion is the most ef-
fective way to eliminate maturing self-reactive T cells 
in ontogeny and early in the life of many higher ver-
tebrates,41 efficient purging of T cells (and possibly 
also B cells) also occurs in the peripheral lymphoid 
organs,42 particularly after transplantation.43 The 
greater the amount of antigen, and the lower the 
number of available immune-cell precursors, the more 
rapid and efficient the establishment of unrespon-
siveness. 
Noncytopllthic Microof'rpJlIiIIms 
Because cytopathic viruses are so rapidly lethal, 
clonal deletion of T cells can be demonstrated only 
by infecting animals with noncytopathic viruses. In-
fection of adult mice with low doses of the non-
cytopathic lymphocytic choriomeningitis virus leads 
to sustained development of cytotoxic T cells that 
eliminate the virus, whereas high doses of virus lead 
to rapid immune activation, followed by deletion of 
the virus-specific T cells and viral persistence (toler-
ance).34 
AIIofIraft. 
Clonal exhaustion-deletion was invoked more than 
three decades ago to explain the observation that af-
ter experimental or clinical organ transplantation, 
the host-graft relation occasionally was so altered 
that immunosuppressive therapy could be discontin-
ued.44 The hypothesis was not widely accepted, be-
cause of the poorly understood role of passenger 
leukocytes. These donor leukocytes make up the 
principal immunogenic component of histoincom-
patible allografts,45,46 an effect that has been attrib-
uted by some to their expression ofMHC class II or 
costimulatory molecules such as B7.8,47 
The rapid disappearance of donor leukocytes from 
successfully transplanted tissues and organs21,45,46,48,49 
was long thought to be caused by their selective de-
struction by the recipient's immune system. After it 
had been demonstrated that the passenger leuko-
cytes migrated to host lymphoid organs,16,17,20 the 
immune destruction was viewed as occurring both 
peripherally and within the graft. Allograft accept-
ance was therefore explained by immune elimination 
of passenger leukocytes in combination with a pan-
oply of other factors, including the appearance of 
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veto, suppressor, or other immune-regulatory cells, 
changes in cytokine profile, and production of anti-
bodies and idiotype networks. It has also been sug-
gested that T cells, both in lymphoid organs and in 
the periphery, may be turned off ("anergized") if 
they encounter appropriately presented antigen in 
the absence of a second signal provided by costimu-
latory molecules.8.47 
Contrary to these hypotheses, we have ascribed 
the ability of donor leukocytes to induce both im-
mune responses and tolerance mainly to their capac-
ity to migrate to and persist in lymphoid organs.l-5,43 
With the discovery of donor leukocytes in lymphoid 
organs and elsewhere in recipients of organ al-
lografts many years after transplantation,4-6 it could 
be suggested that allograft acceptance involves what 
has been described elsewhere as widespread "re-
sponses of co-existing donor and recipient immune 
cells, each to the other, causing reciprocal clonal ex-
pansion, followed by peripheral clonal deletion.'" 
Clonal exhaustion-deletion of the host-versus-graft 
response has been demonstrated in rats after liver 
transplantation. so 
However, the early exhaustion is usually incom-
plete or reversible. Low-level anti_graft18,22,51 or graft-
versus-hostSl reactivity can be detected by in vitro 
assays in cells from many recipients oflong-surviving 
organ allografts. The implication is that a spectrum 
of host-versus-graft and graft-versus-host reactions 
may exist in equilibrium in a transplant recipient, 
ranging from undetectable host-versus-graft as well as 
graft-versus-host responses at one extreme to a pure 
host-versus-graft response (rejection) at the other. 
This hypothesis is consistent with the historical 
argument that acquired tolerance is a dynamic, anti-
gen-dependent stateS2,5a whose outcome is strongly 
influenced both by the dose of donor leukocytes and 
the strength of the host immune response. Donor as 
well as recipient precursor dendritic cells, pluripo-
tent stem cells, and committed cells at various stages 
of differentiation can be found in the lymphoid or-
gans of normal mice that spontaneously tolerate liver 
allografts.54 Under similar experimental conditions, 
the number of donor cells in mouse recipients of 
cardiac allografts is far fewer, and they disappear at 
the same time as the allograft is rejected.54 
Indifference of the Immune System 
Antigens that do not enter organized lymphoid 
tissue do not induce an immune response. This has 
been termed "immune indifference." 
Noncytop«/Jic Microor'gtIm.m. 
In addition to, or instead o~ clonal exhaustion-
deletion, early localization in nonlymphoid sites may 
be necessary for the long-term survival of microor-
ganisms. Even after apparently complete elimina-
tion, some infectious microorganisms may ultimate-
1908 . December 24, 1998 
Iy become inaccessible, in peripheral nonlymphoid 
sites, to memory cytotoxic T lymphocytes or neu-
tralizing antibodies (e.g., papillomaviruses harbored 
by keratinocytes).1-3 
Allograft. 
Induction and maintenance of a T-cell response can 
be prevented by removal of donor leukocytes from thy-
roid5S,56 or other histoincompatible ailografts.4S,46,48,49 
Donor-specific tolerance does not evolve, however, 
and rejection can be precipitated by an immunizing 
injection of donor leukocytes.46,5s,s6 Many similar ex-
periments have confirmed that immune reactivity is 
induced only in lymphoid organs to which alloanti-
gen-expressing donor cells can move directly. 
The importance of alloantigens that are processed 
in and presented with MHC class II molecules by 
host antigen-presenting cells is unclear. 57 Taken col-
lectively, however, the evidence suggests that if the 
cells from allografts do not reach lymphoid organs, 
a specific cytotoxic T-cell response either is not in-
duced or cannot be maintained. 
CLINICAL CORRELATIONS 
The classic host-versus-graft paradigm has provided 
a useful context for in vitro studies of immune func-
tion (e.g., mixed-lymphocyte-culture assays). Howev-
er, the e:trects of live antigen can usually be better 
understood through experiments in animals or clin-
ical observations, particularly if the cells expressing 
antigen include immunocompetent lymphocytes. 
Noncytopathic Microorganisms 
As a general rule, the immune response to acute 
microbial infections is a one-way immune reaction 
(i.e., antimicroorganism).l-3 The survival of some mi-
croorganisms may be facilitated by their ability to re-
lease cytokines ("virokines"), imitate cytokine recep-
tors (e.g., poxviruses), induce products that interact 
with complement components (herpesviruses) or fac-
tors modulating MHC class I molecules (adenovi-
ruses), or modify transcription factors. 58,59 Lympho-
cytic choriomeningitis virus or HlV can even cause 
immunopathologic manifestations resembling graft-
versus-host disease or lead to immunosuppression 
that may help the virus to persist.6o 
Infection with the hepatitis B and C viruses and 
probably other widely disseminated noncytopathic 
microorganisms, such as lymphocytic choriomenin-
gitis virus in mice or HIV in humans, can induce the 
entire spectrum of responses from clonal activation 
to deletion. At one extreme, clonal deletion may 
correlate clinically with an asymptomatic carrier state 
in which immune reactivity is either zero or minimal 
relative to an excessive antigen load (Fig. 2A). Alter-
natively, the early induction of e:trector T cells may 
eliminate detectable viruses rapidly, with resulting 
long-term protective immunity (Fig. 2B). 
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F'lIJure 2. Potential Outcomes after Infection with Noncytopathic Microorganisms and Analogies (Expressed as Rejection or Graft-
versus-Host Disease) to Organ and Bone Marrow Transplantation. 
The horizontal axis denotes time. The vertical axis shows the magnitude of the viral load (V, solid line) and the host immune re-
sponse (lR, dashed line). In Panel 0, the IR is absent (straight dashed line) or minimal. GVHD denotes graft-versus-host disease. 
Some of these apparently eliminated infections 
may never be completely cleared.2,24 Vrruses may 
persist in peripheral nonlymphoid tissues (e.g., hep-
atitis B and C viruses and lymphocytic choriomen-
ingitis virus in the hepatocytes and cytomegalovirus 
in the renal rubules), where they may subsequently 
be ignored. Leakage of small quantities of hidden 
antigen to lymphoid organs may maintain enough 
activated T cells to control the infection efficiently 
but not enough to clear the peripheral foci of organ-
isms.2,24,61,62 
Between the two extremes shown in Figures 2A 
and 2B, an unrelenting immune response to the per-
sisting microorganism expressed in many host cells 
can result in serious immunopathologic conditions 
(e.g., chronic active hepatitis) (Fig. 2C). 
In contrast to these examples of variable immune 
reactivity, other viruses do not initiate an immune 
response for a very long time, because they remain 
outside lymphoid tissues. For example, during a 
variably long period after rabies infection, the virus 
is sequestered in neuronal axons; similarly, human 
papillomavirus is found in warts (Fig. 2D). 
Allografts 
Unlike infection, transplantation usually results in 
a double immune reaction: host-versus-graft and 
graft-versus-host. These responses must persist long 
enough to allow the induction of murual nonreac-
tivity such as that which occurs spontaneously in di-
zygotic calf26 and tamarin63 twins when there is fu-
sion of the two placentas, in parabiosis experiments, 
and after organ transplantation in some mice, rats, 
and pigs.43 
In humans, an umbrella of initially potent inlmu-
nosuppression is required after either organ or bone 
marrow transplantation to avoid acute destruction of 
the leukocytes in the transplant by host cells. Failure 
of such treatment can be defined as the inability to 
control one or both of the two reactions.4,5,43 There 
are many possible clinicopathologic consequences of 
the muwal immunocyte engagement (Fig. 3), which 
are dictated largely by the condition of the recipi-
ent's immune system at the time of transplantation 
and by the dose and lineages of the donor leuko-
CyteS.22 
Organ Tra".",."" 
The objective of immunosuppression in the recip-
ient of an organ transplant is control of the host-ver-
sus-graft reaction (rejection) (Table 1). However, a 
graft-versus-host reaction, which is usually occult, 
may become apparent or even lethal, particularly af-
ter transplantation of leukocyte-rich allografts such 
as the liver or intestine. Graft-versus-host disease is 
diagnosed according to conventional criteria (e.g., 
apoptosis in an area of dermatitis) in approximately 
5 percent of patients who receive hepatic allografts. 
The complication causes death, often with involve-
ment of visceral organs or bone marrow, in about 10 
percent of affected patients, despite increased immu-
nosuppression or other attempts at immune modu-
lation.s 
As with an overwhelming noncytopathic infection, 
an initially strong immune reaction that is pharma-
cologically suppressed may eventually be deleted by 
clonal exhaustion or at least reduced to an accept-
able level (Fig. 2A and 3). In clinical practice, the 
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Figure 3. Contemporaneous Host-versus-Graft (HVGI and Graft-versus-Host (GVH) Reactions after Transplantation. 
Failure is defined as the inability to control one or sometimes both of the reactions. Acute reciprocal clonal exhaustion after suc-
cessful transplantation is subsequently maintained by chimerism-dependent low-grade stimulation of both leukocyte populations, 
which may wax and wane. 
rise and subsequent decline of the immune responses 
are reflected by biochemical indicators of organ func-
tion (e.g., high serum creatinine and bilirubin concen-
trations in kidney and liver recipients, respectively).29,44 
Even if the host-versus-gratt reaction is not severe 
enough to perturb allograft function seriously, serial 
biopsies frequently reveal subclinical rejection that 
may wax and wane. In spontaneously tolerant ani-
mals, such self-resolving histopathological findings 
of rejection are characteristic.18,22.44 Although this 
pattern of immunologic confrontation and resolu-
tion is the same with all organs, liver allografts are 
more likely to induce tolerance than other organs, 
because they contain many hematopoietic cells that 
are capable of traveling to organized lymphoid tissue 
of the recipient, where they induce and exhaust host 
TABlE 1. DlFFERBNCES lIE1WEEN CLINICAL ORGAN 
TRANSPLANTATION AND BONE MARRow TRANSPlANTATION. 
Host cytoablation 
HLA matching 
Principal complication 
Immunosuppression-free 
Term toe success 
No Yes· 
Not essential Critical 
Rejection Grat't-V<!rsus-host disease 
Uncommon Common 
Acceptance Tolerance 
*This therapeutic step allows a relatiV<!1y unopposed graft-V<!rsus-host re-
action and accounts fur the other differences. 
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anti-graft T cells and where the anti-host T cells are 
deleted. 
If the reciprocal deletion does not occur or can-
not be perpentated despite continuous immunosup-
pression, the result can be acute-to-chronic rejection 
or, uncommonly, acute-to-chronic graft-versus-host 
disease (Fig. 2B). We have suggested that allogeneic 
leukocytes in nonlymphoid sites may leak to lymph-
oid organs and maintain donal exhaustion, parallel-
ing the "balanced" state achieved by infectious 
agents.1-3,62 In transplant recipients, T-cell responses 
that are inefficiendy induced or of low strength 
would not be capable of rejecting either the chimeric 
cells or the organ grafts. It is also possible, however, 
that the resulting chronic immune response may 
lead to chronic rejection or even chronic graft-versus-
host disease. After liver transplantation, either of 
these complications may resemble chronic active hep-
atitis (Fig. 2C).64 
It is clear that in addition to causing the host-ver-
sus-graft and graft-versus-host reactions shown in 
Figures lA, 2B, 2C, and 3, the emigration of the pas-
senger leukocytes from a transplanted organ results 
in a fortuitous decline in the allograft's immunoge-
nicity,a-5;43 similar to that which occurs in experiments 
in animals when these cells are removed before or-
gans are transplanted.4s.46.48,49,5S,56 Thus, for com-
pletely successful organ engraftment, four interrelated 
changes must take place in a close temporal relation: 
clonal deletion of the recipient's immune response, 
reciprocal deletion of the donor-leukocyte response, 
maintenance of clonal exhaustion, and a reduction in 
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the immunogenicity of the donor-leukocyte-depleted 
organ. In time, a stable allograft resulting from this 
process may come to resemble a wart3,43 that neither 
readily induces an immune response nor is readily 
reached by immune effector mechanisms (Fig. 2D). 
Bon. MtIITaW TrtIItIIpIsnts 
Pretransplantation cytoablation renders the recipi-
ent susceptible to immune attack by donor immune 
cells (the graft-versus-host reaction), control of which 
frequently becomes the principal objective ofimmu-
nosuppression (Table 1). Since complete destruction 
of host leukocytes is not possible,65 the remaining cells 
will stimulate a response by maOIre or maturing do-
nor T cells. Nevertheless, during immunosuppressive 
treatment, a weak host-versus-graft reaction mount-
ed by these few recipient cells and a parallel graft-ver-
sus-host reaction mounted by the donor bone mar-
row cells may eventually result in reciprocal tolerance 
by deletion. These processes represent a mirror im-
age of the events after organ transplantation (Fig. 2D). 
OTHER MECHANISMS OF TOLERANCE 
Counterregulatory mechanisms of tolerance (e.g., 
suppressor or veto cells and changes in the cytokine 
profile) may be important in some circumstances, dif-
fering according to the model and the time after ex-
posure to antigen. However, they are neither con-
firmed nor understood, and they are not essential for 
the basic argument presented in this review about the 
seminal role of antigen migration and localization. 
The importance of microchimerism has been 
questioned because of the inconsistency with which 
donor leukocytes can be found in blood or tissue 
samples from organ recipients, the development of 
acute or chronic rejection despite chimerism, and 
the inability to use microchimerism to guide post-
transplantation drug weaning. These observations66 
can be readily fitted into the concept of the various 
balanced states that may vary with time and accord-
ing to antigen migration and localization. Within 
this view, donor-leukocyte chimerism is a prerequi-
site for, but not synonymous with and not a conse-
quence o~ the evolution of organ-allograft accept-
ance under clinically relevant circumstances.4,5,43 
This concept has recently been confirmed in a skin-
transplantation model in mice.53 
ADDITIONAL IMPLICATIONS 
The concepts described in this article may help us 
understand other as yet unexplained observations. 
For example, the time needed to establish transplant 
tolerance differs in different species (days or weeks 
in rodents, months or years in humans). The vari-
ability seems to correlate roughly with differences in 
host size, duration of gestation, and lifi:: span but not 
with differences in immune cells, which are strucOIr-
ally and functionally similar in vitro in all mammals. 
T-cell immune function begins in the very early 
stages of fetal development, 8,30,38 suggesting that an-
tigen migration and localization is the basis for the 
ontogeny of the usual nonreactivity to self antigens 
in the same way as it is for acquired tolerance. Au-
toimmune disease would then reflect unacceptable 
postnatal perOIrbations of the prenatally established 
localization of self antigens in nonlymphoid as op-
posed to lymphoid tissuesP 
It will be important to determine what role the 
well-known leakage of semi-allogeneic fetal leuko-
cytes into the maternal circulation has in the survival 
of the conceptus during pregnancy, its rejection at 
parturition, and the health of the mother subse-
quently. In a simation that is analogous to the find-
ings after transplantation, cells of unquestionably fe-
tal origin have been detected in the blood of women 
many years after childbearing, with possible associa-
tions with autoimmune disease.68,69 
CONCLUSIONS 
Short-term effective immune reactivity, or the 
failure to induce an immune response at one ex-
treme as compared with an exhaustive induction of 
all relevant T cells causing deletion at the other ex-
treme, is influenced by dose, timing, route, and lo-
calization of antigen. These factors determine when, 
where, for how long, and with what clinical sequelae 
immune effector functions are or are not induced 
and maintained. Although the relation between in-
fection and transplantation immunity is complicated 
by the presence of contemporaneous host-versus-
graft and graft-versus-host immune reactions and 
the additional factor of therapeutic immunosuppres-
sion after transplantation, the mechanisms and rules 
are basically the same. The simple antigen migra-
tion-localization principle should further our un-
derstanding of the events that occur with or without 
therapeutic intervention in a variety of infectious, 
neoplastic, and autoimmune diseases or after trans-
plantation, and it may offer improved rationales for 
prevention and treatment. 
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